Medical robots are omnipotent but will eventually encounter bottlenecks

According to the 2016-2020 China Medical Robot Industry In-depth Research and Investment Prospects Forecast Report, the global medical device market is expected to reach $514 billion by 2020, growing at a compound annual rate of 5% between 2013 and 2020. By 2020, global investment in medical device R&D is projected to hit $30.5 billion, with a growth rate of around 4.2% from 2013 to 2020. Looking ahead, the future of medical devices is clearly trending toward intelligence, with continuous R&D investments pushing the industry forward. Among these, medical robots are considered the ultimate form of intelligent medical equipment, and their share in the overall market is expected to rise significantly. While North America remains the largest market, the focus is gradually shifting toward Asia. At the CCF·GAIR Global Artificial Intelligence and Robotics Summit held on August 13, 2016, Professor Wang Tianmiao delivered a keynote speech titled “Thinking about the Development of Robots—Academic to Industry.” Before his talk, he briefly discussed the topic of medical robots, which has been a hot subject among researchers and practitioners alike. **From Academia to Industry** When transitioning from academic research to industrial application, where do you think robots will first see significant growth? Professor Wang Tianmiao responded that rising labor costs and increasing land rental expenses may be key drivers for companies to adopt robotics. Currently, high-end robots in China are mostly imported, but low-end industrial robots used in areas like manufacturing, grinding, injection molding, and transportation are becoming more localized. This reflects the current development trend. He believes that in the next five years, we will see the emergence of robot assistants, chatbots, and companion robots in settings such as banks, homes, hotels, and hospitals. **Development Bottlenecks in Medical Robots** A journalist asked whether there are any challenges in transforming medical robots from academic research to practical applications. Wang Tianmiao explained that one of the main differences between medical robots and other types of robots is that they directly involve human life and health, requiring strict safety standards. This means rigorous certification processes and clinical trials, which can take a long time. As a result, the slow pace of development often hinders progress in this field. **Differences Between Academic and Industrial R&D** Given these challenges, how do academic research and industrial practice differ in the development of medical robots? According to Wang, academic research typically starts with a complete system, setting clear goals and implementing safety controls. However, in practice, it's often necessary to focus on specific areas, such as orthopedics or pediatrics, rather than attempting full-scale implementation right away. **Mature Medical Robots in the Market** What are some of the most mature medical robots currently in use? Wang highlighted several examples. The Da Vinci Surgical Robot from the U.S. is widely recognized for its advanced capabilities in minimally invasive surgery. Israel’s Rewalk exoskeleton is notable for helping patients with lower limb paralysis regain mobility. France’s Rosa robot is also widely used in neurosurgery. Domestically, Tianzhihang, which focuses on orthopedic applications, has received regulatory approval and is being used in top hospitals across China. **Da Vinci Surgical Robot** The Da Vinci surgical robot is currently the most advanced robotic-assisted system. Developed by Intuitive Surgical Inc., it represents a new generation of minimally invasive techniques. It combines intelligent robotic arms with high-definition 3D imaging to enable precise, less invasive procedures. The system consists of three main components: the surgeon’s console, the bedside robotic system, and the imaging system. **ReWalk Exoskeleton** ReWalk, developed by Israeli company Rewalk Robotics, is designed to restore walking ability for individuals with lower limb paralysis. Its latest version, ReWalk Personal 6.0, is lighter, more comfortable, and easier to use. It allows users to stand, walk, and even climb stairs with the help of sensors and an optimized algorithm. The product supports customization, making it adaptable for different users. **ROSA Surgical Robot** ROSA, developed by Medtech SA in France, is a leading robotic system used in neurosurgery. Approved in multiple countries, including the U.S., Europe, and China, it has been installed in major neurosurgical centers worldwide. The system enhances precision and efficiency during complex brain surgeries. **Tianzhihang – A Leader in Orthopedic Robotics** Tianzhihang specializes in orthopedic robotics, an area that is well-suited for automation due to its external nature. The company was the first in China to receive a medical robot license with full intellectual property rights. Its products have been deployed in several top hospitals across the country, marking a significant milestone in China’s medical robotics sector.

Faceplate

YLTelecom produces a variety of network faceplate, these faceplates are compatible with our keystone jacks. We have 86 type faceplate, 120 type faceplate, USA Type faceplate,UKtype faceplate, Australian Type Faceplate, French Type Faceplate, and also German Type Faceplate. These faceplate are available with 1 port, 2 port, 3 port, 4 port, 5 port, and 6 port. They are complaint with international standards and with good material. Due to high quality, our faceplate has recognized by international customers for many years.

We are Quality UTP / FTP Network Keystone Jack Plastic Faceplates with Shutter RJ45 Module manufacturers & exporter,we pffer you many type of Faceplate,like Rj45 Faceplate,Telephone Faceplates,86type Face plate.We can promise you the good quality and low price.

Network Faceplate, USB Faceplate, Rj45 Faceplate, Telephone Faceplates

NINGBO YULIANG TELECOM MUNICATIONS EQUIPMENT CO.,LTD. , https://www.yltelecom.com